SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bharat Forge Ltd

Industry : Castings & Forgings

BSE Code

ISIN Demat

Book Value()

500493

INE465A01025

231.3231696

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BHARATFORG

59.76

79881.44

EPS(TTM)

Face Value()

Div & Yield %

27.96

0.51

Back

Aurobindo Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Apr 07,2026

Aurobindo Pharma announced that the final approval is received from the US Food & Drug Administration (USFDA) to manufacture and market Dapagliflozin Tablets, 5 mg and 10 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Farxiga Tablets, 5 mg and 10 mg, of AstraZeneca AB.

These products will be manufactured at Unit-IV of APL Healthcare, a wholly owned subsidiary of the Company and will be launched immediately.

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,596.41 247.62 (2.39%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)